1-8 of 8
Shubhra Ghosh
Close
Sort by
Journal Articles

Hyperacute GVHD: risk factors, outcomes, and clinical implications

Clinical Trials & Observations
Rima M. Saliba, Marcos de Lima, Sergio Giralt, Borje Andersson, Issa F. Khouri, Chitra Hosing, Shubhra Ghosh, Joyce Neumann, Yvonne Hsu, Jorge De Jesus, Muzaffar H. Qazilbash, Richard E. Champlin, Daniel R. Couriel
Journal: Blood
Blood (2006) 109 (7): 2751–2758.
https://doi.org/10.1182/blood-2006-07-034348
Published: 2006
Journal Articles

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Clinical Trials & Observations
Daniel R. Couriel, Chitra Hosing, Rima Saliba, Elizabeth J. Shpall, Paolo Anderlini, Beverly Rhodes, Veronica Smith, Issa Khouri, Sergio Giralt, Marcos de Lima, Yvonne Hsu, Shubhra Ghosh, Joyce Neumann, Borje Andersson, Muzzafar Qazilbash, Sharon Hymes, Stella Kim, Richard Champlin, Michele Donato
Journal: Blood
Blood (2006) 107 (8): 3074–3080.
https://doi.org/10.1182/blood-2005-09-3907
Published: 2006
Journal Articles

Secondary Malignancy after Allogeneic Stem Cell Transplantation: Incidence and Risk Factors.

Chitra Hosing, MD, Rima M. Saliba, PhD, Marcos De Lima, MD, Sergio Giralt, MD, Shubhra Ghosh, MD, Yvonne Hsu, Paolo Anderlini, MD, Sharon R. Hymes, MD, Borje Andersson, MD, Issa F. Khouri, MD, Richard Champlin, MD, Daniel Couriel, MD
Journal: Blood
Blood (2005) 106 (11): 1123.
https://doi.org/10.1182/blood.V106.11.1123.1123
Published: 2005
Journal Articles

Outcomes of Older Patients with Myeloid Leukemias Treated with Myeloablative Intravenous Busulfan-Based Conditioning Regimens and Allogeneic Blood or Marrow Transplantation.

Marcos de Lima, Daniel Couriel, Shubhra Ghosh, Roy B. Jones, Elizabeth J. Shpall, Sergio Giralt, Chitra Hosing, Partow Kebriaei, Richard Champlin, Borje S. Andersson
Journal: Blood
Blood (2005) 106 (11): 660.
https://doi.org/10.1182/blood.V106.11.660.660
Published: 2005
Journal Articles

Clinical, Prognostic and Therapeutic Implications in the Diagnosis of Grade I Acute Graft-Versus-Host Disease.

Rima M. Saliba, PhD, Marcos de Lima, MD, Chitra Hosing, MD, Issa F. Khouri, MD, Sergio Giralt, MD, Paolo Anderlini, MD, Shubhra Ghosh, MD, Kerry Mickler, RN, Cindy Ippoliti, PHARMD, Zuraima Caldera, MD, Yvonne Hsu, PAC, Joyce Neumann, APN, Richard Champlin, MD, Daniel R. Couriel, MD
Journal: Blood
Blood (2005) 106 (11): 1799.
https://doi.org/10.1182/blood.V106.11.1799.1799
Published: 2005
Journal Articles

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Betul Oran, MD, Sergio Giralt, MD, Munir Shahjahan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Shubhra Ghosh, MD, Ernesto de Meis, MD, Michele Donato, MD, Touch Ativivas, MD, Antonio Carrasco-Yalan, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2005) 106 (11): 2019.
https://doi.org/10.1182/blood.V106.11.2019.2019
Published: 2005
Journal Articles

Sequential Treatment with Reduced Intensity Allogeneic Stem Cell Transplantation and Imatinib for Chronic Myelogenous Leukemia (CML.

Richard Champlin, M.D., Shubhra Ghosh, M.D., Gloria McCormick, R.N., Borje Andersson, M.D., Ph.D., Marcos de Lima, M.D., Paolo Anderlini, M.D., Muzaffar Qazilbash, M.D., Sergio Giralt, M.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 812.
https://doi.org/10.1182/blood.V104.11.812.812
Published: 2004
Journal Articles

Hyperacute Graft-Versus-Host Disease: Analysis of Risk Factors, Clinical Manifestations and Outcomes.

Daniel R. Couriel, MD, Rima Saliba, PhD, Marcos J. de Lima, MD, Chitra Hosing, MD, Borje Andersson, MD, Jorge De Jesus, RN, Kerry Mickler, RN, Yvonne Hsu, PA, Elizabeth J. Shpall, MD, Shubhra Ghosh, MD, Richard Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 734.
https://doi.org/10.1182/blood.V104.11.734.734
Published: 2004